Stocks
Tilray Brands, Inc.TLRY
NASDAQHealthcareBiotechnology$4.02-0.86%
Price as of · delayed, not real-time
A leading global cannabis-lifestyle and consumer packaged goods company, Tilray operates across medical and adult-use cannabis markets. Investors monitor its performance as a bellwether for the evolving legal cannabis industry, particularly in North America and Europe.
Market Cap: $697.6M52W Range: $3.67-$23.20
Congressional Interest in Tilray Brands, Inc. (TLRY)
3 members of Congress have disclosed 14 trades in Tilray Brands, Inc. (TLRY), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 9 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
14
Unique Politicians
3
Buys
4
Sells
9
Who in Congress Is Trading TLRY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-05-03 | MICHAEL T. MCCAUL | sell | $15K-$50K |
| 2022-04-18 | Brian Mast | sell | $1K-$15K |
| 2021-05-03 | Brian Mast | exchange | $1K-$15K |
| 2021-02-12 | John A. Yarmuth | buy | $1K-$15K |
| 2021-02-10 | Brian Mast | sell | $50K-$100K |
| 2021-02-10 | Brian Mast | sell | $50K-$100K |
| 2021-02-09 | Brian Mast | sell | $15K-$50K |
| 2021-02-09 | Brian Mast | sell | $15K-$50K |
| 2021-02-09 | Brian Mast | sell | $15K-$50K |
| 2021-02-09 | Brian Mast | sell | $15K-$50K |
| 2020-11-06 | Brian Mast | buy | $15K-$50K |
| 2020-11-05 | John A. Yarmuth | buy | $1K-$15K |
| 2019-02-04 | Brian Mast | sell | $15K-$50K |
| 2019-01-18 | Brian Mast | buy | $15K-$50K |